SI-BONE, Inc. (SIBN) is a Healthcare stock trading at $15.85 (as of 2026-06-18), with a market capitalization of $625.32M and a trailing P/E of -36.2. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
SI-BONE, Inc. develops implantable medical devices for musculoskeletal conditions affecting the sacropelvic region, including sacroiliac joint dysfunction and related degeneration, adult deformity, and pelvic ring traumatic fractures. Its product lines include the iFuse implant system and variants such as iFuse-3D and iFuse-TORQ, which are sold in the United States and internationally through a direct sales force and distributors.